References
Mechoulam R, Vogel Z, Barg J. CNS cannabinoid receptors: role and therapeutic indications for CNS disorders. CNS Drugs 1994; 2(4): 255–60
1995 Physicians GenRx. St. Louis, Missouri: Mosby-Year Book, Inc. 1995; 688–91
Von Roenn JH. Management of HIV-related bodyweight loss. Drugs 1994 May; 47(5): 774–83
Lane M, Smith FE, Sullivan RA, et al. Dronabinol and prochlorperazine alone and in combination as antiemetic agents for cancer chemotherapy. Am J Clin Oncol 1990; 13(6): 480–4
Struwe M, Kaempfer SH, Geiger CJ, et al. Effect of dronabinol on nutritional status in HIV infection. Ann Pharmacother 1993 Jul/Aug; 27: 827–31
Beal JE, Olson R, Laubenstein L, et al. Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS. J Pain Symptom Manage 1995 Feb; 10(2): 89–97
Wong R. Pharmacological treatments for HIV/AIDS-related anorexia. PT 1994 Jul; 19: 708, 711–2, 715, 719–21
Henahan S. Dronabinol gives AIDS patients a boost. Inpharma 1993 Jun 19; (892): 3
Cannabis compound to be prescribable in UK. Pharm J 1995 Aug 19; 255:234
Rights and permissions
About this article
Cite this article
Medical uses for dronabinol, the active constituent of marijuana. Drugs Ther. Perspect 6, 8–9 (1995). https://doi.org/10.2165/00042310-199506110-00003
Published:
Issue Date:
DOI: https://doi.org/10.2165/00042310-199506110-00003